Page last updated: 2024-10-26

dipyridamole and Capillary Leak Syndrome

dipyridamole has been researched along with Capillary Leak Syndrome in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Capillary Leak Syndrome: A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, Y2
Wan, H1
Du, M1
Deng, H1
Fu, J1
Wang, X1
Liu, R1

Other Studies

1 other study available for dipyridamole and Capillary Leak Syndrome

ArticleYear
Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report.
    Medicine, 2018, Volume: 97, Issue:23

    Topics: Aspirin; Capillary Leak Syndrome; Dipyridamole; Diuretics; Furosemide; Glucocorticoids; Humans; Immu

2018